Furthermore, another study on BC patients receiving anthracycline-based neoadjuvant chemotherapy revealed no correlation between NT-proBNP elevation and sST2, while supporting the potential use of sST2 in the sensitive and early identification of cardiomyopathy linked to anthracycline-based BC chemotherapy [58]. This evidence concerns the gene NPPB and cardiomyopathy.